Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Xenetic Biosciences (XBIO) Revenue (2023 - 2025)

Xenetic Biosciences (XBIO) has disclosed Revenue for 6 consecutive years, with $1.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue rose 67.19% year-over-year to $1.0 million, compared with a TTM value of $2.9 million through Sep 2025, up 13.3%, and an annual FY2024 reading of $2.5 million, down 1.56% over the prior year.
  • Revenue was $1.0 million for Q3 2025 at Xenetic Biosciences, up from $589897.0 in the prior quarter.
  • Across five years, Revenue topped out at $1.0 million in Q3 2025 and bottomed at $510817.0 in Q1 2024.
  • Average Revenue over 3 years is $659125.9, with a median of $614243.0 recorded in 2024.
  • Peak annual rise in Revenue hit 67.19% in 2025, while the deepest fall reached 18.79% in 2025.
  • Year by year, Revenue stood at $671963.0 in 2023, then dropped by 3.44% to $648820.0 in 2024, then skyrocketed by 58.28% to $1.0 million in 2025.
  • Business Quant data shows Revenue for XBIO at $1.0 million in Q3 2025, $589897.0 in Q2 2025, and $593261.0 in Q1 2025.